Wayland Group (MRRC.F) Stock Overview

Produces and sells medical marijuana in Canada and internationally. More details

MRRC.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($237)

Shares are highly illiquid

High level of non-cash earnings

Latest financial reports are more than a year old

MRRC.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW437,476 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

437,476 investors already sharing narratives

View all narratives

Wayland Group Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Wayland Group
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.00001
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	0%
1 Year Change	0%
3 Year Change	-90.00%
5 Year Change	-99.90%
Change since IPO	-99.90%

Recent updates

Shareholder Returns

	MRRC.F	US Pharmaceuticals	US Market
7D	0%	-4.0%	-2.2%
1Y	0%	43.7%	13.1%

Return vs Industry: MRRC.F underperformed the US Pharmaceuticals industry which returned 45.8% over the past year.

Return vs Market: MRRC.F underperformed the US Market which returned 14.8% over the past year.

Price Volatility

Is MRRC.F's price volatile compared to industry and market?
MRRC.F volatility
MRRC.F Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	8.8%
Market Average Movement	6.9%
10% most volatile stocks in US Market	15.4%
10% least volatile stocks in US Market	2.9%

Stable Share Price: MRRC.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine MRRC.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2013	n/a	n/a	n/a

Wayland Group Corp. produces and sells medical marijuana in Canada and internationally. The company was founded in 2013 and is based Burlington, Canada.

Wayland Group Corp. Fundamentals Summary

How do Wayland Group's earnings and revenue compare to its market cap?
MRRC.F fundamental statistics
Market cap	US$237.00
Earnings (TTM)	-US$31.09m
Revenue (TTM)	US$1.94m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is MRRC.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MRRC.F income statement (TTM)
Revenue	CA$2.68m
Cost of Revenue	CA$4.80m
Gross Profit	-CA$2.12m
Other Expenses	CA$40.84m
Earnings	-CA$42.96m

Last Reported Earnings

Sep 30, 2018

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did MRRC.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/09/10 08:23
End of Day Share Price	2026/09/03 00:00
Earnings	2018/09/30
Annual Earnings	2017/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Wayland Group Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Neil Maruoka	Canaccord Genuity

Wayland Group Corp.OTCPK:MRRC.F Stock Report